Borden Ladner Gervais LLP | Canada | 21 Nov 2022
On November 18, 2022, the Supreme Court of Canada (SCC) released its much-awaited decision in the case of Nova Chemicals Corporation v. Dow Chemical…
Borden Ladner Gervais LLP | Canada | 29 Sep 2022
The most significant changes to the Canadian patent system in more than two decades come into effect on October 3, 2022.1 Several of these changes…
Borden Ladner Gervais LLP | Canada | 29 Aug 2022
The Federal Court recently denied AbbVie’s application for judicial review of two decisions of the Minister of Health (the Minister) relating to JAMP…
Borden Ladner Gervais LLP | Canada | 22 Jul 2022
On July 15, 2022, the Supreme Court of Canada (SCC) released its decision in Society of Composers, Authors and Music Publishers of Canada v…
Borden Ladner Gervais LLP | Canada | 7 Jul 2022
The Competition Bureau (the Bureau) in Canada has a long history of investigating business matters relating to innovative pharmaceutical companies in…
Borden Ladner Gervais LLP | Canada | 25 Apr 2022
The theme of World Intellectual Property Day this year is "IP and Youth: Innovating for a Better Future." In the spirit of contributing to…
Borden Ladner Gervais LLP | Canada | 19 Apr 2022
On March 29, 2022 the Government of Canada (Federal Government) delivered its 2030 Emissions Reduction Plan (the Plan);The Plan outlines current and…
Borden Ladner Gervais LLP | Canada | 11 Apr 2022
Amongst the other areas highlighted in the Foreword of the 2022 Federal Budget (Budget 2022), IP is specifically identified: “We will help Canadians…
Borden Ladner Gervais LLP | Canada | 8 Apr 2022
On March 29, 2022, the Federal Government delivered its 2030 Emissions Reduction Plan (the Plan). It is clear that the Plan strives to be…
Borden Ladner Gervais LLP | Canada | 14 Jan 2022
In the context of a motion for summary judgment in Kobold Corporation et al v. NCS Multistage Inc., the Court provided the first judicial…